These 15 Words From Pfizer's CFO Could Translate to Billions in Sales for Its COVID Vaccine
Pfizer (NYSE: PFE) expects to generate revenue of more than $60 billion this year. That's over 40% higher than the giant drugmaker's revenue in 2020. You might think that with that kind of growth on the way, Pfizer's shares would be on fire right now, but they're not. The stock is actually down a little year to date.
Probably the main reason that's the case is that investors don't know whether or not to expect similar revenue for Pfizer in 2022 and beyond. It's uncertain if the company's COVID-19 vaccine BNT162b2 will be able to rake in robust recurring revenue after the pandemic ends.
However, Pfizer seems to think that it will. The company's CFO recently uttered 15 words that could translate to billions of dollars of additional sales for its COVID vaccine.
Source Fool.com
